v3.24.4
SCHEDULE OF OTHER INCOME, GAINS OR LOSSES (Details) - USD ($)
 6 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Notes and other explanatory information [abstract]        
Preferred shares $ 3,539,648 [1] $ 5,044,000 [1] $ 4,101,000 [2] $ (1,841,000) [2]
Convertible loan notes (274,000) [3] (126,000) [3] (374,000) [4] (19,000) [4]
Bank interest income 71 332 873 576
Subsidies from government authorities 12,806 19,230 19,230 67,433
Other 6 6,866 6,885 29,581
Other income, gains or losses $ 3,278,531 $ 4,944,428 $ 3,753,988 $ (1,762,410)
[1] The preferred shares were fair valued, using an equity allocation model at the end of each reporting period, which resulted in a gain of $3,539,648 for the period ended 30 September 2024 (30 September 2023: a gain of $5,044,000).
[2] The preferred shares were fair valued, using an equity allocation model at the end of each reporting period, which resulted in a gain of $4,101,000 for the year ended 31 March 2024 (2023: loss of $1,841,000).
[3] The Group has issued 8% convertible loan notes. At 30 September 2024, there were $4,350,000 notes outstanding (30 September 2023: $3,350,000). The notes were fair valued at the end of each reporting period, resulting in a loss of $274,000 during the period ended 30 September 2024 (30 September 2023: loss of $126,000).
[4] During the year ended 31 March 2024 and 2023, the Group issued 8% convertible loan notes. At 31 March 2024, there were outstanding notes with aggregate face values of $3,350,000 (2023: $3,250,000). The notes were fair valued at the end of each reporting period, resulting in a loss of $374,000 for the year ended 31 March 2024 (2023: loss of $19,000).